Following previous studies, evidencing that SOD administration can decrease the severity of respiratory illness, the authors propose to better evaluate if lung-specific delivery of SOD3 related antioxidants, in combination to other anti-virals, may improve COVID-19 outcomes in the elderly. The gene discussed is SOD3; the disease is COVID-19.